Tech Company Financing Transactions
PHASE Scientific Funding Round
On 5/19/2025, PHASE Scientific raised $34 million in Series A funding from Value Partners and private investors.
Transaction Overview
Company Name
Announced On
5/19/2025
Transaction Type
Venture Equity
Amount
$34,000,000
Round
Series A
Investors
Value Partners (Lead Investor) (Chuen Leung)
Proceeds Purpose
With this capital, we will accelerate R&D and commercialization efforts to bring a comprehensive suite of next-generation urine-based diagnostics to market.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Building 22E, Phase 3, Hong Kong Science Park, Shatin 1/F
Hong Kong, Undisclosed
Hong Kong
Hong Kong, Undisclosed
Hong Kong
Phone
Website
Email Address
Overview
PHASE Scienti?c is a high-growth biotech company; Headquartered in Hong Kong with locations in Southern California and China's Greater Bay Area, we provide novel diagnostic tools and services for cancer and infectious diseases with our proprietary technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ricky Chiu
Chief Financial Officer
Leslie Chow
Chief Operating Officer
Johnny Wang
Chief Technical Officer
Daniel Marshak
General Manager
Felix Chao
General Manager
Jenny Chiu
VP - Bus. Development
Jason Ho
VP - Human Resources
Bing Liu
VP - Product Management
Kent Cheng
Browse more venture capital transactions:
Prev: 5/19/2025: Theo Ai venture capital transaction
Next: 5/19/2025: RoboForce venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs